| 183.43 BATS BZX Real-Time Price As of 1:53pm ET |  -1.01 / -0.55%Today’s Change | 166.30 Today|||52-Week Range 210.19 | -5.77% Year-to-Date |
| Previous close | 184.44 |
| Today’s open | 184.52 |
| Day’s range | 182.81 - 184.94 |
| Volume | 889,008 |
| Average volume (3 months) | 2,869,645 |
| Market cap | $113.9B |
| Earnings growth (last year) | +368.59% |
| Earnings growth (this year) | -2.54% |
| Earnings growth (next 5 years) | +6.00% |
| Revenue growth (last year) | +4.32% |
| P/E ratio | 14.6 |
| Price/Sales | 5.45 |
| Price/Book | 9.41 |
| Today’s change | Today’s % change | |
|---|---|---|
| GILDGilead Sciences | -1.01 | -1.47% |
| ILMNIllumina Inc | -1.63 | -0.46% |
| BIIBBiogen | -2.50 | -1.04% |
| EXASExact Sciences Corp | +1.64 | +1.47% |
| Next reporting date | July 29, 2019 |
| EPS forecast (this quarter) | $3.59 |
| Annual revenue (last year) | $23.8B |
| Annual profit (last year) | $8.4B |
| Net profit margin | 35.32% |
Sector Health Technology |
Industry Biotechnology |
Chairman & Chief Executive Officer Robert A. Bradway |
Executive Vice President- Operations Esteban Santos |
Corporate headquarters Thousand Oaks, California |
